Clinical Trials Browser

OTHER × Other solid neoplasm × Clear all

NCT04959097 2026-04-22

rbliqbx

Other solid neoplasm

Retinoblastoma

NCT07545291 2026-04-22

A Spiritual Health Intervention (PATH) for Improving Spiritual, Religious and Emotional Distress in Cancer Patients

Phase NA Not yet recruiting

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT07545486 2026-04-22

ATOM-1st

Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT07541573 2026-04-21

Phase 1a/1b GTB-5550 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Tri-specific Killer Engager

NCT03810339 2026-04-20

Toripalimab as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07538479 2026-04-20

NIVALIS

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT07215039 2026-04-17

Improving Prison Health Equity Through Cancer Literacy and Screening Awareness in Florida

Enrolling by invitation

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT05035667 2026-04-16

Patient Considerations of Social Media Account Management After Death

Active not recruiting

Other solid neoplasm

Advanced Malignant Solid Neoplasm

NCT06066424 2026-04-16

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

Phase 1 Recruiting

Other solid neoplasm

Solid Tumors

NCT06576037 2026-04-16

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06598371 2026-04-16

A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Select Advanced Solid Tumors

NCT06638931 2026-04-15

ANTARES

Phase 2 Recruiting

BreastCNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETOther solid neoplasmSarcomaThoracic

Urachal adenocarcinoma, Urachal cancer, Fibrolamellar hepatocellular carcinoma, Secretory breast carcinoma, Carcinoma, Ovarian Epithelial, Adrenal Gland Neoplasms, Anus Neoplasms, Biliary Tract Neoplasms, Carcinosarcoma, Carcinoma, Adenoid Cystic, Fallopian Tube Neoplasms, Fibrosarcoma, Gallbladder Neoplasms, Granulosa Cell Tumor, Hemangiosarcoma, Leiomyosarcoma, Mesothelioma, Neuroblastoma, Parathyroid Neoplasms, Penile Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Thyroid Neoplasms, Trophoblastic Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Hepatoblastoma, Endodermal Sinus Tumor, Neuroectodermal Tumors, Primitive, Cholangiocarcinoma, Sertoli-Leydig Cell Tumor, Neurofibrosarcoma, Hemangioblastoma, Neuroendocrine Tumors

NCT07530458 2026-04-15

Retinoblastoma Consolidation in Egyptians

Not yet recruiting

Other solid neoplasm

Retinoblastoma

NCT03016156 2026-04-14

Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma

Phase NA Terminated

Other solid neoplasm

Hydrophthalmos, Retinoblastoma

NCT03447483 2026-04-14

MOTIVATE

Phase NA Completed

Other solid neoplasm

Solid Tumor

NCT05071846 2026-04-14

MVX-ONCO-2 in Advanced Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT07529002 2026-04-14

Clinical Application of 89Zr-s-C1 PET/CT Imaging in Solid Tumors

Other solid neoplasm

Solid Tumors

NCT06198010 2026-04-13

ASCENT

Phase NA Recruiting

Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT06709404 2026-04-13

Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

Phase NA Recruiting

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT07040943 2026-04-13

Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.

Phase 1 Recruiting

Other solid neoplasm

Refractory Malignant Solid Tumors

NCT07141407 2026-04-13

Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person

Phase NA Recruiting

Other solid neoplasm

Advanced Malignant Solid Neoplasm

NCT06130254 2026-04-09

Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers

Phase 1 Terminated

Other solid neoplasmThoracic

Advanced Solid Tumor

NCT07225920 2026-04-08

PGA

Phase NA Enrolling by invitation

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT06383598 2026-04-07

PD-L1 Specific [68Ga]Ga-THP-PDL1-3 Probe for PET Imaging in Solid Tumors

Phase NA Recruiting

Other solid neoplasm

Solid Tumor

NCT06798701 2026-04-07

Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation

Phase NA Recruiting

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT07059884 2026-04-07

DEFEND

Phase NA Recruiting

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT07443020 2026-04-07

RIOT 4B

Phase 1 Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT07514793 2026-04-07

Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma

Phase 2 Not yet recruiting

Other solid neoplasmThoracic

Mesothelioma

NCT05873608 2026-04-06

Communication Issues in Patient and Provider Discussions of Immunotherapy

Phase NA Recruiting

Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT06306638 2026-04-06

Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction

Phase 1/2 Recruiting

Other solid neoplasm

Malignant Solid Neoplasm

NCT05521984 2026-04-02

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Phase 1 Recruiting

Other solid neoplasm

Pediatric Brain Tumor

NCT06682117 2026-04-02

Neo-DCV-001

Phase NA Recruiting

Other solid neoplasm

Treatment

NCT06630351 2026-04-01

Group Meaning-Centered Psychotherapy for the Improvement of Wellbeing in Caregivers of Patients With Serious Illness

Phase NA Enrolling by invitation

Other solid neoplasm

Advanced Malignant Solid Neoplasm

NCT07504445 2026-03-31

Clinical Study on the Efficacy and Safety of CAR-DC in the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT05036226 2026-03-30

COAST

Phase 1/2 Recruiting

GenitourinaryOther solid neoplasm

Prostate Cancer Recurrent

NCT05223608 2026-03-30

ImmuCCo

Phase NA Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05655078 2026-03-30

HIT-Meso

Phase NA Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT06342453 2026-03-30

CREATE: Art for Children With Cancer

Phase NA Recruiting

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT06395441 2026-03-30

Wisconsin Ginseng for Decreasing Cancer Related Fatigue

Phase 3 Recruiting

Other solid neoplasm

Malignant Solid Neoplasm

NCT07089927 2026-03-30

Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Survivors, AVATARS Trial

Phase NA Recruiting

Other solid neoplasm

Malignant Solid Neoplasm

NCT00477958 2026-03-27

Assessment Tool for Older Patients With Cancer

Phase NA Active not recruiting

Other solid neoplasm

Cognitive/Functional Effects

NCT03678350 2026-03-27

Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery

Phase 1 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Pleural Diseases

NCT03997370 2026-03-27

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Phase 1 Active not recruiting

Other solid neoplasm

Malignant Solid Neoplasm

NCT04450043 2026-03-27

The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance

Phase NA Active not recruiting

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Small Cell Lung Carcinoma

NCT07306338 2026-03-27

Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT07480733 2026-03-25

Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors

Phase 2 Not yet recruiting

Other solid neoplasm

Advanced Malignant Solid Tumors

NCT06651593 2026-03-24

Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Solid Tumors

NCT06827054 2026-03-24

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

Phase 2 Not yet recruiting

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT07490236 2026-03-24

Trilaciclib in Combination With Chemotherapy in Patients With CDK4/6-Dependent Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Trilaciclib

NCT02215720 2026-03-20

TORERO

Phase 1 Completed

Other solid neoplasm

Patients With Advanced or Metastatic Solid Tumors